ArticleMedicine2025
Predictive and prognostic models and visualizations of distant metastasis in gallbladder cancer.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Temporal trends in the incidence and prognosis of lung metastasis in gallbladder cancer: risk stratification and survival analysis.American journal of cancer research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Employing multivariate statistical methods, we aimed to construct and validate predictive models for distant metastasis (DM) risk and overall survival (OS) in patients with gallbladder cancer (GBC), using data from the surveillance, epidemiology, and end results database maintained by the National Cancer Institute. These models were visualized through the development of intuitive nomograms. We extracted clinical data of all patients diagnosed with GBC between 2010 and 2015 from the surveillance, epidemiology, and end results database. Both univariate and multivariate logistic regression analyses were conducted utilizing R software (Version 4.2.1) to identify independent risk predictors for DM in GBC patients, and univariate and multivariate Cox regression analyses were performed to determine independent prognostic factors for OS among GBC patients with DM. The discriminatory capabilities and predictive accuracies of the developed nomograms were examined through calibration curves, receiver operating characteristic curves, and decision curve analysis. In our study, 3071 patients with GBC were included, of which 759 (24.72%) had DM. Race, T stage, N stage, and tumor size were identified as independent risk factors for DM, while age, surgical intervention, and chemotherapy were independent prognostic factors for OS in GBC patients with DM. The area under the curve for the prognostic nomogram reached 0.726 and 0.730 in the training and validation sets, respectively. The area under the curve for the same nomogram at 6, 9, and 12 months was 0.744, 0.740, and 0.704 for the training set, and 0.798, 0.774, and 0.776 for the validation set, respectively. The calibration curves, decision curve analysis, and Kaplan-Meier survival curves further demonstrated the effectiveness of the nomograms in predicting DM occurrence and the prognosis of GBC patients with DM. Race, T stage, N stage, and tumor size emerged as independent risk factors for DM in GBC patients; whereas age, surgical treatment, and chemotherapy were found to be independent prognostic factors for OS in GBC patients with DM. We successfully established and validated a predictive nomogram for DM occurrence and a prognostic nomogram for OS in GBC patients with DM, both showing high accuracy and clinical utility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.